nodes	percent_of_prediction	percent_of_DWPC	metapath
Floxuridine—TYMP—Fluorouracil—skin cancer	0.503	0.653	CbGbCtD
Floxuridine—TYMS—Fluorouracil—skin cancer	0.267	0.347	CbGbCtD
Floxuridine—Biliary fibrosis—Fluorouracil—skin cancer	0.0215	0.125	CcSEcCtD
Floxuridine—Onychomadesis—Fluorouracil—skin cancer	0.00893	0.052	CcSEcCtD
Floxuridine—Skin toxicity—Bleomycin—skin cancer	0.00831	0.0484	CcSEcCtD
Floxuridine—Nail changes—Bleomycin—skin cancer	0.0066	0.0385	CcSEcCtD
Floxuridine—Onychomadesis—Docetaxel—skin cancer	0.00644	0.0376	CcSEcCtD
Floxuridine—TYMP—endothelium—skin cancer	0.00554	0.149	CbGeAlD
Floxuridine—Nail changes—Fluorouracil—skin cancer	0.00513	0.0299	CcSEcCtD
Floxuridine—TYMP—blood vessel—skin cancer	0.00511	0.138	CbGeAlD
Floxuridine—Skin toxicity—Docetaxel—skin cancer	0.00466	0.0272	CcSEcCtD
Floxuridine—Cerebellar syndrome—Fluorouracil—skin cancer	0.00371	0.0216	CcSEcCtD
Floxuridine—Nail changes—Docetaxel—skin cancer	0.0037	0.0216	CcSEcCtD
Floxuridine—Ischaemia—Imiquimod—skin cancer	0.00369	0.0215	CcSEcCtD
Floxuridine—TYMP—nipple—skin cancer	0.00369	0.0995	CbGeAlD
Floxuridine—Zidovudine—TERT—skin cancer	0.00346	1	CrCbGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00304	0.221	CbGpPWpGaD
Floxuridine—TYMP—connective tissue—skin cancer	0.00262	0.0706	CbGeAlD
Floxuridine—TYMS—Sorafenib—Vismodegib—skin cancer	0.00251	0.584	CbGdCrCtD
Floxuridine—TYMS—connective tissue—skin cancer	0.00225	0.0606	CbGeAlD
Floxuridine—TYMP—mammalian vulva—skin cancer	0.00216	0.0581	CbGeAlD
Floxuridine—TYMS—skin of body—skin cancer	0.00203	0.0547	CbGeAlD
Floxuridine—TYMP—lymphoid tissue—skin cancer	0.00191	0.0516	CbGeAlD
Floxuridine—TYMS—mammalian vulva—skin cancer	0.00185	0.0499	CbGeAlD
Floxuridine—TYMP—female reproductive system—skin cancer	0.00185	0.0498	CbGeAlD
Floxuridine—TYMS—Paclitaxel—Docetaxel—skin cancer	0.00179	0.416	CbGdCrCtD
Floxuridine—TYMS—lymphoid tissue—skin cancer	0.00164	0.0443	CbGeAlD
Floxuridine—TYMS—female reproductive system—skin cancer	0.00158	0.0427	CbGeAlD
Floxuridine—Enteritis—Docetaxel—skin cancer	0.00157	0.00916	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—XRCC3—skin cancer	0.00156	0.113	CbGpPWpGaD
Floxuridine—TYMP—head—skin cancer	0.00154	0.0416	CbGeAlD
Floxuridine—Nail disorder—Bleomycin—skin cancer	0.00148	0.0086	CcSEcCtD
Floxuridine—Rash maculo-papular—Vemurafenib—skin cancer	0.00144	0.00837	CcSEcCtD
Floxuridine—TYMS—head—skin cancer	0.00132	0.0357	CbGeAlD
Floxuridine—Photosensitivity—Vemurafenib—skin cancer	0.00131	0.00761	CcSEcCtD
Floxuridine—Lacrimation—Fluorouracil—skin cancer	0.00127	0.00738	CcSEcCtD
Floxuridine—Embolism—Temozolomide—skin cancer	0.00126	0.00733	CcSEcCtD
Floxuridine—Nail disorder—Fluorouracil—skin cancer	0.00115	0.00669	CcSEcCtD
Floxuridine—Alopecia—Vismodegib—skin cancer	0.00114	0.00662	CcSEcCtD
Floxuridine—Duodenal ulcer—Docetaxel—skin cancer	0.00111	0.00648	CcSEcCtD
Floxuridine—TYMP—lymph node—skin cancer	0.00108	0.0291	CbGeAlD
Floxuridine—Muscle spasms—Vismodegib—skin cancer	0.00108	0.00627	CcSEcCtD
Floxuridine—TYMP—Fluoropyrimidine Activity—ERCC2—skin cancer	0.00107	0.0777	CbGpPWpGaD
Floxuridine—Dry skin—Vemurafenib—skin cancer	0.00105	0.00613	CcSEcCtD
Floxuridine—Nystagmus—Fluorouracil—skin cancer	0.00104	0.00607	CcSEcCtD
Floxuridine—Lethargy—Imiquimod—skin cancer	0.000998	0.00582	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDK4—skin cancer	0.000944	0.0686	CbGpPWpGaD
Floxuridine—TYMS—lymph node—skin cancer	0.000927	0.025	CbGeAlD
Floxuridine—Myocardial ischaemia—Fluorouracil—skin cancer	0.000926	0.0054	CcSEcCtD
Floxuridine—Lacrimation—Docetaxel—skin cancer	0.000913	0.00532	CcSEcCtD
Floxuridine—Photosensitivity reaction—Vemurafenib—skin cancer	0.000905	0.00527	CcSEcCtD
Floxuridine—Nervous system disorder—Vismodegib—skin cancer	0.000895	0.00522	CcSEcCtD
Floxuridine—Embolism—Docetaxel—skin cancer	0.000837	0.00488	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—BRAF—skin cancer	0.000836	0.0607	CbGpPWpGaD
Floxuridine—Nail disorder—Docetaxel—skin cancer	0.000828	0.00483	CcSEcCtD
Floxuridine—Lacrimation increased—Fluorouracil—skin cancer	0.000807	0.00471	CcSEcCtD
Floxuridine—Pancytopenia—Imiquimod—skin cancer	0.000803	0.00468	CcSEcCtD
Floxuridine—Decreased appetite—Vismodegib—skin cancer	0.000793	0.00462	CcSEcCtD
Floxuridine—Disorientation—Bleomycin—skin cancer	0.000777	0.00453	CcSEcCtD
Floxuridine—Photosensitivity reaction—Imiquimod—skin cancer	0.000772	0.0045	CcSEcCtD
Floxuridine—Gastrointestinal pain—Vismodegib—skin cancer	0.000746	0.00435	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—CDKN2A—skin cancer	0.000722	0.0524	CbGpPWpGaD
Floxuridine—Abdominal pain—Vismodegib—skin cancer	0.000721	0.0042	CcSEcCtD
Floxuridine—Alopecia—Vemurafenib—skin cancer	0.000701	0.00409	CcSEcCtD
Floxuridine—Photophobia—Fluorouracil—skin cancer	0.000699	0.00407	CcSEcCtD
Floxuridine—Erythema—Vemurafenib—skin cancer	0.000691	0.00403	CcSEcCtD
Floxuridine—Haemoglobin—Imiquimod—skin cancer	0.00068	0.00396	CcSEcCtD
Floxuridine—Thrombophlebitis—Temozolomide—skin cancer	0.000677	0.00395	CcSEcCtD
Floxuridine—Haemorrhage—Imiquimod—skin cancer	0.000677	0.00394	CcSEcCtD
Floxuridine—Rash maculo-papular—Fluorouracil—skin cancer	0.000676	0.00394	CcSEcCtD
Floxuridine—Pharyngitis—Imiquimod—skin cancer	0.000672	0.00391	CcSEcCtD
Floxuridine—Myocardial ischaemia—Docetaxel—skin cancer	0.000668	0.00389	CcSEcCtD
Floxuridine—Lethargy—Dactinomycin—skin cancer	0.000661	0.00386	CcSEcCtD
Floxuridine—Gastroenteritis—Temozolomide—skin cancer	0.000661	0.00386	CcSEcCtD
Floxuridine—Asthenia—Vismodegib—skin cancer	0.000655	0.00382	CcSEcCtD
Floxuridine—Euphoric mood—Fluorouracil—skin cancer	0.000639	0.00373	CcSEcCtD
Floxuridine—Diarrhoea—Vismodegib—skin cancer	0.000624	0.00364	CcSEcCtD
Floxuridine—Thrombophlebitis—Fluorouracil—skin cancer	0.000624	0.00364	CcSEcCtD
Floxuridine—Photosensitivity—Fluorouracil—skin cancer	0.000615	0.00359	CcSEcCtD
Floxuridine—Disorientation—Fluorouracil—skin cancer	0.000604	0.00352	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—XRCC1—skin cancer	0.000599	0.0435	CbGpPWpGaD
Floxuridine—Alopecia—Imiquimod—skin cancer	0.000598	0.00349	CcSEcCtD
Floxuridine—Erythema—Imiquimod—skin cancer	0.000589	0.00343	CcSEcCtD
Floxuridine—Lacrimation increased—Docetaxel—skin cancer	0.000583	0.0034	CcSEcCtD
Floxuridine—Vomiting—Vismodegib—skin cancer	0.00058	0.00338	CcSEcCtD
Floxuridine—Rash—Vismodegib—skin cancer	0.000575	0.00335	CcSEcCtD
Floxuridine—Dermatitis—Vismodegib—skin cancer	0.000575	0.00335	CcSEcCtD
Floxuridine—Pancytopenia—Bleomycin—skin cancer	0.00057	0.00332	CcSEcCtD
Floxuridine—Anaphylactic shock—Vemurafenib—skin cancer	0.000564	0.00329	CcSEcCtD
Floxuridine—Infection—Vemurafenib—skin cancer	0.00056	0.00326	CcSEcCtD
Floxuridine—Nervous system disorder—Vemurafenib—skin cancer	0.000553	0.00322	CcSEcCtD
Floxuridine—Lethargy—Fluorouracil—skin cancer	0.000551	0.00321	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—ERCC2—skin cancer	0.000548	0.0398	CbGpPWpGaD
Floxuridine—Ill-defined disorder—Imiquimod—skin cancer	0.000547	0.00319	CcSEcCtD
Floxuridine—Nausea—Vismodegib—skin cancer	0.000542	0.00316	CcSEcCtD
Floxuridine—Dry skin—Temozolomide—skin cancer	0.000537	0.00313	CcSEcCtD
Floxuridine—Pancytopenia—Dactinomycin—skin cancer	0.000532	0.0031	CcSEcCtD
Floxuridine—Malaise—Imiquimod—skin cancer	0.000531	0.0031	CcSEcCtD
Floxuridine—Stomatitis—Bleomycin—skin cancer	0.000522	0.00304	CcSEcCtD
Floxuridine—Discomfort—Imiquimod—skin cancer	0.000496	0.00289	CcSEcCtD
Floxuridine—Dry skin—Fluorouracil—skin cancer	0.000495	0.00289	CcSEcCtD
Floxuridine—Decreased appetite—Vemurafenib—skin cancer	0.00049	0.00286	CcSEcCtD
Floxuridine—Stomatitis—Dactinomycin—skin cancer	0.000487	0.00284	CcSEcCtD
Floxuridine—Haemoglobin—Bleomycin—skin cancer	0.000483	0.00282	CcSEcCtD
Floxuridine—Pancytopenia—Temozolomide—skin cancer	0.000481	0.0028	CcSEcCtD
Floxuridine—Haemorrhage—Bleomycin—skin cancer	0.000481	0.0028	CcSEcCtD
Floxuridine—Infection—Imiquimod—skin cancer	0.000478	0.00278	CcSEcCtD
Floxuridine—Nervous system disorder—Imiquimod—skin cancer	0.000472	0.00275	CcSEcCtD
Floxuridine—Agranulocytosis—Dactinomycin—skin cancer	0.000466	0.00272	CcSEcCtD
Floxuridine—Photosensitivity reaction—Temozolomide—skin cancer	0.000462	0.0027	CcSEcCtD
Floxuridine—Anorexia—Imiquimod—skin cancer	0.000458	0.00267	CcSEcCtD
Floxuridine—Angina pectoris—Fluorouracil—skin cancer	0.000455	0.00265	CcSEcCtD
Floxuridine—Thrombophlebitis—Docetaxel—skin cancer	0.00045	0.00262	CcSEcCtD
Floxuridine—Body temperature increased—Vemurafenib—skin cancer	0.000446	0.0026	CcSEcCtD
Floxuridine—Pharyngitis—Dactinomycin—skin cancer	0.000445	0.00259	CcSEcCtD
Floxuridine—Pancytopenia—Fluorouracil—skin cancer	0.000443	0.00258	CcSEcCtD
Floxuridine—Stomatitis—Temozolomide—skin cancer	0.00044	0.00257	CcSEcCtD
Floxuridine—Photosensitivity reaction—Fluorouracil—skin cancer	0.000426	0.00248	CcSEcCtD
Floxuridine—Alopecia—Bleomycin—skin cancer	0.000425	0.00248	CcSEcCtD
Floxuridine—Erythema—Bleomycin—skin cancer	0.000419	0.00244	CcSEcCtD
Floxuridine—Decreased appetite—Imiquimod—skin cancer	0.000418	0.00244	CcSEcCtD
Floxuridine—Hypersensitivity—Vemurafenib—skin cancer	0.000415	0.00242	CcSEcCtD
Floxuridine—Haemoglobin—Temozolomide—skin cancer	0.000408	0.00238	CcSEcCtD
Floxuridine—Stomatitis—Fluorouracil—skin cancer	0.000406	0.00236	CcSEcCtD
Floxuridine—Haemorrhage—Temozolomide—skin cancer	0.000406	0.00236	CcSEcCtD
Floxuridine—Asthenia—Vemurafenib—skin cancer	0.000404	0.00236	CcSEcCtD
Floxuridine—Pharyngitis—Temozolomide—skin cancer	0.000403	0.00235	CcSEcCtD
Floxuridine—TYMP—Bladder Cancer—TP53—skin cancer	0.000402	0.0292	CbGpPWpGaD
Floxuridine—Lethargy—Docetaxel—skin cancer	0.000398	0.00232	CcSEcCtD
Floxuridine—Alopecia—Dactinomycin—skin cancer	0.000396	0.00231	CcSEcCtD
Floxuridine—Feeling abnormal—Imiquimod—skin cancer	0.000396	0.00231	CcSEcCtD
Floxuridine—Gastrointestinal pain—Imiquimod—skin cancer	0.000393	0.00229	CcSEcCtD
Floxuridine—Epistaxis—Fluorouracil—skin cancer	0.000393	0.00229	CcSEcCtD
Floxuridine—Erythema—Dactinomycin—skin cancer	0.00039	0.00228	CcSEcCtD
Floxuridine—Agranulocytosis—Fluorouracil—skin cancer	0.000388	0.00226	CcSEcCtD
Floxuridine—Ill-defined disorder—Bleomycin—skin cancer	0.000388	0.00226	CcSEcCtD
Floxuridine—Anaemia—Bleomycin—skin cancer	0.000387	0.00225	CcSEcCtD
Floxuridine—Diarrhoea—Vemurafenib—skin cancer	0.000386	0.00225	CcSEcCtD
Floxuridine—TYMS—Circadian rythm related genes—NKX2-1—skin cancer	0.000384	0.0279	CbGpPWpGaD
Floxuridine—TYMP—Bladder Cancer—HRAS—skin cancer	0.000384	0.0279	CbGpPWpGaD
Floxuridine—TYMP—Fluoropyrimidine Activity—TP53—skin cancer	0.000382	0.0277	CbGpPWpGaD
Floxuridine—Abdominal pain—Imiquimod—skin cancer	0.00038	0.00222	CcSEcCtD
Floxuridine—Body temperature increased—Imiquimod—skin cancer	0.00038	0.00222	CcSEcCtD
Floxuridine—Malaise—Bleomycin—skin cancer	0.000377	0.0022	CcSEcCtD
Floxuridine—Haemoglobin—Fluorouracil—skin cancer	0.000376	0.00219	CcSEcCtD
Floxuridine—Leukopenia—Bleomycin—skin cancer	0.000375	0.00218	CcSEcCtD
Floxuridine—Haemorrhage—Fluorouracil—skin cancer	0.000374	0.00218	CcSEcCtD
Floxuridine—Pharyngitis—Fluorouracil—skin cancer	0.000371	0.00216	CcSEcCtD
Floxuridine—Ill-defined disorder—Dactinomycin—skin cancer	0.000362	0.00211	CcSEcCtD
Floxuridine—Anaemia—Dactinomycin—skin cancer	0.000361	0.0021	CcSEcCtD
Floxuridine—Vomiting—Vemurafenib—skin cancer	0.000358	0.00209	CcSEcCtD
Floxuridine—Alopecia—Temozolomide—skin cancer	0.000358	0.00209	CcSEcCtD
Floxuridine—Dry skin—Docetaxel—skin cancer	0.000357	0.00208	CcSEcCtD
Floxuridine—Rash—Vemurafenib—skin cancer	0.000355	0.00207	CcSEcCtD
Floxuridine—Dermatitis—Vemurafenib—skin cancer	0.000355	0.00207	CcSEcCtD
Floxuridine—Hypersensitivity—Imiquimod—skin cancer	0.000354	0.00206	CcSEcCtD
Floxuridine—Headache—Vemurafenib—skin cancer	0.000353	0.00206	CcSEcCtD
Floxuridine—Erythema—Temozolomide—skin cancer	0.000353	0.00206	CcSEcCtD
Floxuridine—Discomfort—Bleomycin—skin cancer	0.000352	0.00205	CcSEcCtD
Floxuridine—Malaise—Dactinomycin—skin cancer	0.000352	0.00205	CcSEcCtD
Floxuridine—Cramp muscle—Docetaxel—skin cancer	0.000351	0.00205	CcSEcCtD
Floxuridine—Leukopenia—Dactinomycin—skin cancer	0.000349	0.00204	CcSEcCtD
Floxuridine—Asthenia—Imiquimod—skin cancer	0.000345	0.00201	CcSEcCtD
Floxuridine—Confusional state—Bleomycin—skin cancer	0.000344	0.00201	CcSEcCtD
Floxuridine—Anaphylactic shock—Bleomycin—skin cancer	0.000342	0.00199	CcSEcCtD
Floxuridine—Infection—Bleomycin—skin cancer	0.000339	0.00198	CcSEcCtD
Floxuridine—Nausea—Vemurafenib—skin cancer	0.000335	0.00195	CcSEcCtD
Floxuridine—Thrombocytopenia—Bleomycin—skin cancer	0.000334	0.00195	CcSEcCtD
Floxuridine—Alopecia—Fluorouracil—skin cancer	0.00033	0.00192	CcSEcCtD
Floxuridine—Diarrhoea—Imiquimod—skin cancer	0.000329	0.00192	CcSEcCtD
Floxuridine—Discomfort—Dactinomycin—skin cancer	0.000328	0.00191	CcSEcCtD
Floxuridine—Angina pectoris—Docetaxel—skin cancer	0.000328	0.00191	CcSEcCtD
Floxuridine—Ill-defined disorder—Temozolomide—skin cancer	0.000328	0.00191	CcSEcCtD
Floxuridine—Anaemia—Temozolomide—skin cancer	0.000326	0.0019	CcSEcCtD
Floxuridine—Anorexia—Bleomycin—skin cancer	0.000326	0.0019	CcSEcCtD
Floxuridine—Erythema—Fluorouracil—skin cancer	0.000325	0.0019	CcSEcCtD
Floxuridine—Pancytopenia—Docetaxel—skin cancer	0.00032	0.00187	CcSEcCtD
Floxuridine—Malaise—Temozolomide—skin cancer	0.000318	0.00186	CcSEcCtD
Floxuridine—Infection—Dactinomycin—skin cancer	0.000316	0.00184	CcSEcCtD
Floxuridine—Leukopenia—Temozolomide—skin cancer	0.000316	0.00184	CcSEcCtD
Floxuridine—Thrombocytopenia—Dactinomycin—skin cancer	0.000312	0.00182	CcSEcCtD
Floxuridine—Vomiting—Imiquimod—skin cancer	0.000306	0.00178	CcSEcCtD
Floxuridine—Anorexia—Dactinomycin—skin cancer	0.000304	0.00177	CcSEcCtD
Floxuridine—Rash—Imiquimod—skin cancer	0.000303	0.00177	CcSEcCtD
Floxuridine—Dermatitis—Imiquimod—skin cancer	0.000303	0.00177	CcSEcCtD
Floxuridine—Headache—Imiquimod—skin cancer	0.000301	0.00176	CcSEcCtD
Floxuridine—Anaemia—Fluorouracil—skin cancer	0.000301	0.00175	CcSEcCtD
Floxuridine—Discomfort—Temozolomide—skin cancer	0.000297	0.00173	CcSEcCtD
Floxuridine—Decreased appetite—Bleomycin—skin cancer	0.000297	0.00173	CcSEcCtD
Floxuridine—Stomatitis—Docetaxel—skin cancer	0.000293	0.00171	CcSEcCtD
Floxuridine—Leukopenia—Fluorouracil—skin cancer	0.000291	0.0017	CcSEcCtD
Floxuridine—Confusional state—Temozolomide—skin cancer	0.000291	0.00169	CcSEcCtD
Floxuridine—Anaphylactic shock—Temozolomide—skin cancer	0.000288	0.00168	CcSEcCtD
Floxuridine—Infection—Temozolomide—skin cancer	0.000286	0.00167	CcSEcCtD
Floxuridine—Nausea—Imiquimod—skin cancer	0.000286	0.00166	CcSEcCtD
Floxuridine—Epistaxis—Docetaxel—skin cancer	0.000283	0.00165	CcSEcCtD
Floxuridine—Nervous system disorder—Temozolomide—skin cancer	0.000283	0.00165	CcSEcCtD
Floxuridine—Thrombocytopenia—Temozolomide—skin cancer	0.000282	0.00164	CcSEcCtD
Floxuridine—Feeling abnormal—Bleomycin—skin cancer	0.000281	0.00164	CcSEcCtD
Floxuridine—Agranulocytosis—Docetaxel—skin cancer	0.00028	0.00163	CcSEcCtD
Floxuridine—Decreased appetite—Dactinomycin—skin cancer	0.000277	0.00161	CcSEcCtD
Floxuridine—Anorexia—Temozolomide—skin cancer	0.000275	0.0016	CcSEcCtD
Floxuridine—Discomfort—Fluorouracil—skin cancer	0.000274	0.00159	CcSEcCtD
Floxuridine—Haemoglobin—Docetaxel—skin cancer	0.000271	0.00158	CcSEcCtD
Floxuridine—Body temperature increased—Bleomycin—skin cancer	0.00027	0.00157	CcSEcCtD
Floxuridine—Haemorrhage—Docetaxel—skin cancer	0.00027	0.00157	CcSEcCtD
Floxuridine—Confusional state—Fluorouracil—skin cancer	0.000268	0.00156	CcSEcCtD
Floxuridine—Pharyngitis—Docetaxel—skin cancer	0.000268	0.00156	CcSEcCtD
Floxuridine—Anaphylactic shock—Fluorouracil—skin cancer	0.000265	0.00155	CcSEcCtD
Floxuridine—Infection—Fluorouracil—skin cancer	0.000264	0.00154	CcSEcCtD
Floxuridine—Feeling abnormal—Dactinomycin—skin cancer	0.000263	0.00153	CcSEcCtD
Floxuridine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00026	0.00152	CcSEcCtD
Floxuridine—Nervous system disorder—Fluorouracil—skin cancer	0.00026	0.00152	CcSEcCtD
Floxuridine—Thrombocytopenia—Fluorouracil—skin cancer	0.00026	0.00152	CcSEcCtD
Floxuridine—Anorexia—Fluorouracil—skin cancer	0.000253	0.00147	CcSEcCtD
Floxuridine—Abdominal pain—Dactinomycin—skin cancer	0.000252	0.00147	CcSEcCtD
Floxuridine—Body temperature increased—Dactinomycin—skin cancer	0.000252	0.00147	CcSEcCtD
Floxuridine—Hypersensitivity—Bleomycin—skin cancer	0.000252	0.00147	CcSEcCtD
Floxuridine—Decreased appetite—Temozolomide—skin cancer	0.00025	0.00146	CcSEcCtD
Floxuridine—Asthenia—Bleomycin—skin cancer	0.000245	0.00143	CcSEcCtD
Floxuridine—Alopecia—Docetaxel—skin cancer	0.000238	0.00139	CcSEcCtD
Floxuridine—Feeling abnormal—Temozolomide—skin cancer	0.000237	0.00138	CcSEcCtD
Floxuridine—Gastrointestinal pain—Temozolomide—skin cancer	0.000236	0.00137	CcSEcCtD
Floxuridine—Erythema—Docetaxel—skin cancer	0.000235	0.00137	CcSEcCtD
Floxuridine—Hypersensitivity—Dactinomycin—skin cancer	0.000235	0.00137	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	0.000231	0.0168	CbGpPWpGaD
Floxuridine—Decreased appetite—Fluorouracil—skin cancer	0.000231	0.00135	CcSEcCtD
Floxuridine—Asthenia—Dactinomycin—skin cancer	0.000229	0.00133	CcSEcCtD
Floxuridine—Abdominal pain—Temozolomide—skin cancer	0.000228	0.00133	CcSEcCtD
Floxuridine—Body temperature increased—Temozolomide—skin cancer	0.000228	0.00133	CcSEcCtD
Floxuridine—Muscle spasms—Docetaxel—skin cancer	0.000226	0.00132	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	0.000219	0.0159	CbGpPWpGaD
Floxuridine—Feeling abnormal—Fluorouracil—skin cancer	0.000219	0.00128	CcSEcCtD
Floxuridine—Diarrhoea—Dactinomycin—skin cancer	0.000218	0.00127	CcSEcCtD
Floxuridine—Vomiting—Bleomycin—skin cancer	0.000217	0.00127	CcSEcCtD
Floxuridine—Anaemia—Docetaxel—skin cancer	0.000217	0.00126	CcSEcCtD
Floxuridine—Rash—Bleomycin—skin cancer	0.000215	0.00126	CcSEcCtD
Floxuridine—Dermatitis—Bleomycin—skin cancer	0.000215	0.00125	CcSEcCtD
Floxuridine—Hypersensitivity—Temozolomide—skin cancer	0.000212	0.00124	CcSEcCtD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—CDK4—skin cancer	0.000212	0.0154	CbGpPWpGaD
Floxuridine—Leukopenia—Docetaxel—skin cancer	0.00021	0.00122	CcSEcCtD
Floxuridine—Body temperature increased—Fluorouracil—skin cancer	0.00021	0.00122	CcSEcCtD
Floxuridine—Asthenia—Temozolomide—skin cancer	0.000207	0.0012	CcSEcCtD
Floxuridine—Nausea—Bleomycin—skin cancer	0.000203	0.00118	CcSEcCtD
Floxuridine—Vomiting—Dactinomycin—skin cancer	0.000203	0.00118	CcSEcCtD
Floxuridine—Rash—Dactinomycin—skin cancer	0.000201	0.00117	CcSEcCtD
Floxuridine—Diarrhoea—Temozolomide—skin cancer	0.000197	0.00115	CcSEcCtD
Floxuridine—Hypersensitivity—Fluorouracil—skin cancer	0.000196	0.00114	CcSEcCtD
Floxuridine—TYMS—Fluoropyrimidine Activity—TP53—skin cancer	0.000195	0.0142	CbGpPWpGaD
Floxuridine—Confusional state—Docetaxel—skin cancer	0.000193	0.00113	CcSEcCtD
Floxuridine—Anaphylactic shock—Docetaxel—skin cancer	0.000192	0.00112	CcSEcCtD
Floxuridine—Infection—Docetaxel—skin cancer	0.00019	0.00111	CcSEcCtD
Floxuridine—Nausea—Dactinomycin—skin cancer	0.000189	0.0011	CcSEcCtD
Floxuridine—Nervous system disorder—Docetaxel—skin cancer	0.000188	0.0011	CcSEcCtD
Floxuridine—Thrombocytopenia—Docetaxel—skin cancer	0.000188	0.00109	CcSEcCtD
Floxuridine—TYMS—E2F transcription factor network—CDKN2A—skin cancer	0.000186	0.0135	CbGpPWpGaD
Floxuridine—Vomiting—Temozolomide—skin cancer	0.000183	0.00107	CcSEcCtD
Floxuridine—Anorexia—Docetaxel—skin cancer	0.000183	0.00106	CcSEcCtD
Floxuridine—Rash—Temozolomide—skin cancer	0.000182	0.00106	CcSEcCtD
Floxuridine—Diarrhoea—Fluorouracil—skin cancer	0.000182	0.00106	CcSEcCtD
Floxuridine—Dermatitis—Temozolomide—skin cancer	0.000182	0.00106	CcSEcCtD
Floxuridine—Headache—Temozolomide—skin cancer	0.000181	0.00105	CcSEcCtD
Floxuridine—Nausea—Temozolomide—skin cancer	0.000171	0.000998	CcSEcCtD
Floxuridine—Vomiting—Fluorouracil—skin cancer	0.000169	0.000984	CcSEcCtD
Floxuridine—Rash—Fluorouracil—skin cancer	0.000167	0.000976	CcSEcCtD
Floxuridine—Dermatitis—Fluorouracil—skin cancer	0.000167	0.000975	CcSEcCtD
Floxuridine—Decreased appetite—Docetaxel—skin cancer	0.000167	0.000971	CcSEcCtD
Floxuridine—Headache—Fluorouracil—skin cancer	0.000166	0.000969	CcSEcCtD
Floxuridine—Feeling abnormal—Docetaxel—skin cancer	0.000158	0.00092	CcSEcCtD
Floxuridine—Nausea—Fluorouracil—skin cancer	0.000158	0.000919	CcSEcCtD
Floxuridine—Gastrointestinal pain—Docetaxel—skin cancer	0.000157	0.000913	CcSEcCtD
Floxuridine—TYMP—Metabolism—PLIN2—skin cancer	0.000154	0.0111	CbGpPWpGaD
Floxuridine—Body temperature increased—Docetaxel—skin cancer	0.000151	0.000883	CcSEcCtD
Floxuridine—Abdominal pain—Docetaxel—skin cancer	0.000151	0.000883	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDK4—skin cancer	0.000149	0.0108	CbGpPWpGaD
Floxuridine—Hypersensitivity—Docetaxel—skin cancer	0.000141	0.000823	CcSEcCtD
Floxuridine—Asthenia—Docetaxel—skin cancer	0.000137	0.000801	CcSEcCtD
Floxuridine—Diarrhoea—Docetaxel—skin cancer	0.000131	0.000764	CcSEcCtD
Floxuridine—TYMP—Metabolism—CSPG4—skin cancer	0.000124	0.00899	CbGpPWpGaD
Floxuridine—Vomiting—Docetaxel—skin cancer	0.000122	0.00071	CcSEcCtD
Floxuridine—Rash—Docetaxel—skin cancer	0.000121	0.000704	CcSEcCtD
Floxuridine—Dermatitis—Docetaxel—skin cancer	0.000121	0.000704	CcSEcCtD
Floxuridine—Headache—Docetaxel—skin cancer	0.00012	0.0007	CcSEcCtD
Floxuridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—skin cancer	0.000114	0.00826	CbGpPWpGaD
Floxuridine—Nausea—Docetaxel—skin cancer	0.000114	0.000663	CcSEcCtD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	0.000113	0.00819	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—CDK4—skin cancer	0.000108	0.00786	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—MLH1—skin cancer	9.61e-05	0.00697	CbGpPWpGaD
Floxuridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—skin cancer	9e-05	0.00653	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ENO2—skin cancer	8.42e-05	0.00611	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	8.06e-05	0.00585	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PLIN2—skin cancer	7.86e-05	0.0057	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—CSPG4—skin cancer	6.33e-05	0.0046	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDK4—skin cancer	5.46e-05	0.00396	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TERT—skin cancer	5.46e-05	0.00396	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.4e-05	0.00392	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—ERCC2—skin cancer	4.89e-05	0.00355	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDK4—skin cancer	4.88e-05	0.00354	CbGpPWpGaD
Floxuridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.8e-05	0.00348	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—TP53—skin cancer	4.61e-05	0.00334	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ENO2—skin cancer	4.3e-05	0.00312	CbGpPWpGaD
Floxuridine—TYMS—Circadian rythm related genes—IL6—skin cancer	4.22e-05	0.00306	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle, Mitotic—CDKN2A—skin cancer	4.17e-05	0.00303	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—CDKN2A—skin cancer	3.73e-05	0.00271	CbGpPWpGaD
Floxuridine—TYMP—Metabolism—PTGS2—skin cancer	2.93e-05	0.00213	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—ERCC2—skin cancer	2.5e-05	0.00181	CbGpPWpGaD
Floxuridine—TYMS—Cell Cycle—TP53—skin cancer	2.08e-05	0.00151	CbGpPWpGaD
Floxuridine—TYMS—Metabolism—PTGS2—skin cancer	1.5e-05	0.00109	CbGpPWpGaD
